Replenishment and enrichment of ocular surface lubrication
US8506944B2 · kind B2 · utility
31Cited by
14References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 23, 2009 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Jan 12, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An ophthalmic composition, and methods of use thereof, including for treating ocular boundary deficiency, symptoms associated therewith, or undesired condition that is associated with or causes ocular boundary deficiency at the ocular surface or for the treatment or care of ophthalmic devices. The ophthalmic composition comprises a human PRG4 protein, a lubricant fragment, homolog, or isoform thereof, suspended in an ophthalmically acceptable balanced salt solution. The ophthalmic composition may also comprise one or more ophthalmically acceptable agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.